Decreases in Nephrotoxic Pain Medications Are Not Associated With Increased Opioid Utilization in Critically Ill Children.


Journal

Pediatric critical care medicine : a journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies
ISSN: 1529-7535
Titre abrégé: Pediatr Crit Care Med
Pays: United States
ID NLM: 100954653

Informations de publication

Date de publication:
01 12 2022
Historique:
pubmed: 7 9 2022
medline: 6 12 2022
entrez: 6 9 2022
Statut: ppublish

Résumé

Quality improvement initiatives to decrease rates of nephrotoxic medication exposure have reduced rates of acute kidney injury (AKI) in noncritically ill children. The objective of our study was to analyze the implementation of a similar program in critically ill children and to measure important balancing measures including opioid and benzodiazepine exposure. Prospective quality improvement study. PICU at Children's Hospital Colorado between 2018 and 2020. All children admitted to PICU. Quality improvement initiative called Nephrotoxic Injury Negated by Just-In-Time Action (NINJA). Eight thousand eight hundred thirty-three PICU patient admissions were included. Mean rates of nephrotoxic medication exposure/1,000 PICU patient days decreased from 46 to 26, whereas rates of nephrotoxic AKI/1,000 PICU patient days did not change. Nonsteroidal anti-inflammatory drug dispenses per 1,000 patient days were reduced from 521 to 456. Similarly, opioid and benzodiazepine exposures per 1,000 patient days were reduced from 812 to 524 and 441 to 227, respectively, during the study observation period. The NINJA intervention was efficaciously implemented in our single-center PICU. Nephrotoxic exposure is a modifiable factor that did not inadvertently increase exposure to opioids and benzodiazepines.

Identifiants

pubmed: 36066647
doi: 10.1097/PCC.0000000000003072
pii: 00130478-202212000-00020
doi:

Substances chimiques

Analgesics, Opioid 0
Benzodiazepines 12794-10-4

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e564-e573

Informations de copyright

Copyright © 2022 by the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies.

Déclaration de conflit d'intérêts

Dr. Martin disclosed that she is analyst for Epic. The remaining authors have disclosed that they do not have any potential conflicts of interest.

Références

Kaddourah A, Basu RK, Bagshaw SM, et al.; AWARE Investigators: Epidemiology of acute kidney injury in critically ill children and young adults. N Engl J Med 2017; 376:11–20
Askenazi DJ, Feig DI, Graham NM, et al.: 3-5 year longitudinal follow-up of pediatric patients after acute renal failure. Kidney Int 2006; 69:184–189
Menon S, Kirkendall ES, Nguyen H, et al.: Acute kidney injury associated with high nephrotoxic medication exposure leads to chronic kidney disease after 6 months. J Pediatr 2014; 165:522–7.e2
Xiong M, Wang L, Su L, et al.: Acute kidney injury among hospitalized children with cancer. Pediatr Nephrol 2021; 36:171–179
Alobaidi R, Morgan C, Goldstein SL, et al.: Population-based epidemiology and outcomes of acute kidney injury in critically ill children. Pediatr Crit Care Med 2020; 21:82–91
Alobaidi R, Anton N, Burkholder S, et al.: Association between acute kidney injury duration and outcomes in critically ill children. Pediatr Crit Care Med 2021; 22:642–650
Sigurjonsdottir VK, Chaturvedi S, Mammen C, et al.: Pediatric acute kidney injury and the subsequent risk for chronic kidney disease: Is there cause for alarm? Pediatr Nephrol 2018; 33:2047–2055
Starr MC, Banks R, Reeder RW, et al.; Life After Pediatric Sepsis Evaluation (LAPSE) Investigators: Severe acute kidney injury is associated with increased risk of death and new morbidity after pediatric septic shock. Pediatr Crit Care Med 2020; 21:e686–e695
De Zan F, Amigoni A, Pozzato R, et al.: Acute kidney injury in critically ill children: A retrospective analysis of risk factors. Blood Purif 2020; 49:1–7
Goldstein SL, Dahale D, Kirkendall ES, et al.: A prospective multi-center quality improvement initiative (NINJA) indicates a reduction in nephrotoxic acute kidney injury in hospitalized children. Kidney Int 2020; 97:580–588
Goldstein SL, Kirkendall E, Nguyen H, et al.: Electronic health record identification of nephrotoxin exposure and associated acute kidney injury. Pediatrics 2013; 132:e756–e767
Goldstein SL, Mottes T, Simpson K, et al.: A sustained quality improvement program reduces nephrotoxic medication-associated acute kidney injury. Kidney Int 2016; 90:212–221
Stoops C, Stone S, Evans E, et al.: Baby NINJA (nephrotoxic injury negated by just-in-time action): Reduction of nephrotoxic medication-associated acute kidney injury in the neonatal intensive care unit. J Pediatr 2019; 215:223–228.e6
Uber AM, Montez-Rath ME, Kwiatkowski DM, et al.: Nephrotoxin exposure and acute kidney injury in critically ill children undergoing congenital cardiac surgery. Pediatr Nephrol 2018; 33:2193–2199
Slater MB, Gruneir A, Rochon PA, et al.: Identifying high-risk medications associated with acute kidney injury in critically ill patients: A pharmacoepidemiologic evaluation. Paediatr Drugs 2017; 19:59–67
Moffett BS, Goldstein SL: Acute kidney injury and increasing nephrotoxic-medication exposure in noncritically-ill children. Clin J Am Soc Nephrol 2011; 6:856–863
Lexi-drugs online: Opioid Conversion Table and Morphine Equivalent Dose Table. Hudson, OH, Lexicomp, Inc. 2016. Available at: http://www.crlonline.com/lco/action/doc/retrieve/docid/patch_f/4153?cesid=1sqeeARb75z&searchUrl=%2Flco%2Faction%2Fsearch%3Fq%3Dopioid%26t%3Dname%26acs%3Dfalse%26acq%3Dopioid . Accessed August 24, 2022
Brady PW, Tchou MJ, Ambroggio L, et al.: Quality improvement feature series article 2: Displaying and analyzing quality improvement data. J Pediatric Infect Dis Soc 2018; 7:100–103
Martin M, Wilson FP: Utility of electronic medical record alerts to prevent drug nephrotoxicity. Clin J Am Soc Nephrol 2019; 14:115–123
Oh J, Bia JR, Ubaid-Ullah M, et al.: Provider acceptance of an automated electronic alert for acute kidney injury. Clin Kidney J 2016; 9:567–571
Young J, Dahale D, Demmel K, et al.: Reducing acute kidney injury in pediatric oncology patients: An improvement project targeting nephrotoxic medications. Pediatr Blood Cancer 2020; 67:e28396
Benoit SW, Goldstein SL, Dahale DS, et al.: Reduction in nephrotoxic antimicrobial exposure decreases associated acute kidney injury in pediatric hematopoietic stem cell transplant patients. Biol Blood Marrow Transplant 2019; 25:1654–1658
Sutherland SM, Kwiatkowski DM: Acute kidney injury in children. Adv Chronic Kidney Dis 2017; 24:380–387
Vet NJ, Ista E, de Wildt SN, et al.: Optimal sedation in pediatric intensive care patients: A systematic review. Intensive Care Med 2013; 39:1524–1534
Chiu AW, Contreras S, Mehta S, et al.: Iatrogenic opioid withdrawal in critically ill patients: A review of assessment tools and management. Ann Pharmacother 2017; 51:1099–1111
Anand KJ, Willson DF, Berger J, et al.; Eunice Kennedy Shriver National Institute of Child Health and Human Development Collaborative Pediatric Critical Care Research Network: Tolerance and withdrawal from prolonged opioid use in critically ill children. Pediatrics 2010; 125:e1208–e1225
Kudchadkar SR, Yaster M, Punjabi AN, et al.: Temporal characteristics of the sleep EEG power spectrum in critically ill children. J Clin Sleep Med 2015; 11:1449–1454

Auteurs

Erin K Stenson (EK)

Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.

Gina DeMasellis (G)

Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.

Ananya Shah (A)

Pharmacy, University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, Children's Hospital Colorado, Aurora, CO.

Pamela D Reiter (PD)

Section of Pediatric Critical Care, Department of Pediatrics, University of Colorado School of Medicine and Children's Hospital Colorado, Aurora, CO.

John Brinton (J)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Sara Martin (S)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Melissa Iwanowski (M)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Michael Rannie (M)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Danielle E Soranno (DE)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Katja M Gist (KM)

Analytics Resource Center, Children's Hospital Colorado, Aurora, CO.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH